Omega-3 attacks AD
February 18, 2014
A SWEDISH study has
demonstrated a positive impact on
markers for Alzheimer’s Disease
(AD) from a daily dose of 2.3 grams
of omega-3 supplement.
Dr Freund Levi of Karolinska
University Hospital, Huddinge,
Sweden and colleagues conducted
the study as a sub-study of patients
included in the larger doubleblind,
placebo-controlled OmegAD
study, which also observed that in
patients with mild AD.
“Together, these findings support
the hypothesis that increased
oral intake of omega-3 fatty acids
leads to their accumulation in
central nervous tissues and may
affect nervous system physiology
as well as the pathogenesis and
progression of Alzheimer’s disease,
particularly in very mild Alzheimer’s
disease,” they concluded.
Another recent study at the
University of South Australia
found that omega-3 supplements
diminished shortening of telomeres,
a marker of accelerated ageing, in
elderly patients with mild cognitive
impairment.
According to the Australian
Institute of Health and Welfare,
dementia is the second leading
cause of overall burden of disease
in Australia for people aged over
65 years.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Feb 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Feb 14
